by Simona Gilman | Feb 18, 2020 | Articles, Featured Posts, Oncology
Mike J. Mason ● Carolina Schinke ● Christine L. P. Eng ● Fadi Towfic ● Fred Gruber ● Andrew Dervan ● Brian S. White ● Aditya Pratapa ● Yuanfang Guan8 ● Hongjie Chen ● Yi Cui10 ● Bailiang Li ● Thomas Yu ● Elias Chaibub Neto ● Konstantinos Mavrommatis ● Maria Ortiz ●...
by wpengine | Jan 8, 2020 | Featured Posts, News
Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia’s Medicare Advantage population that could benefit from an extra layer of support. Read the full article...
by Simona Gilman | Jan 5, 2020 | Featured Posts, Press Releases
Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...
by wpengine | Nov 18, 2019 | Featured Posts, News
Sema Sgaier and Francesca Domini of Surgo Foundation share how they causal AI can bring new clarity to understanding the underlying cause of disease. Read the full article here.
by gnsadmin | Nov 15, 2019 | Events, Featured Posts
On November 12 GNS Healthcare scientists were joined by Dr. Alan Venook of UCLA and the Alliance for Clinical Trials in Oncology to discuss understanding what drugs work for whom in the context of colorectal cancer. To view the webinar recording or download the...
by wpengine | Jul 9, 2019 | Featured Posts, News
Forbes contributor Bruce Japsen notes that the Cigna investment “fits the effort by health insurance companies to use claims data and related patient health information to better target illness and provide more cost-effective and high quality patient care. These...
